Physician

Ryan T Rogers, MD

According to 2025 Medicare claims, Ryan Rogers, MD (NPI: 1396065470) practices dermatology in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is PADRE DERMATOLOGY PLLC (NPI: 1215302427; TIN: 475198542) and primary practice location at 78418-9998.

Rogers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 738 traditional Medicare patients, billed 4,579 HCPCS/CPT codes, and received $459,962 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 757 prescription claims across 385 beneficiaries totaling $13,478 in drug costs, led by Acitretin (Acitretin). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $118,790 to $459,962. In contrast, Part D prescription costs have fallen sharply in recent years, from $35,219 to $13,478. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$238K$477K2016 Medicare payment: $118,790 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $267,522 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $269,999 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $312,446 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $252,049 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $455,265 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $476,640 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $305,476 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $459,962 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20164401,306$118,790
20176722,741$267,522
20186162,945$269,999
20196433,385$312,446
20205383,053$252,049
20218103,586$455,265
20228504,378$476,640
20236333,473$305,476
20247384,579$459,962

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$230K$459K2015 Drug cost: $35,219 (USD; Tot_Drug_Cst)2016 Drug cost: $45,878 (USD; Tot_Drug_Cst)2017 Drug cost: $182,615 (USD; Tot_Drug_Cst)2018 Drug cost: $422,041 (USD; Tot_Drug_Cst)2019 Drug cost: $446,492 (USD; Tot_Drug_Cst)2020 Drug cost: $459,443 (USD; Tot_Drug_Cst)2021 Drug cost: $230,943 (USD; Tot_Drug_Cst)2022 Drug cost: $11,337 (USD; Tot_Drug_Cst)2023 Drug cost: $14,621 (USD; Tot_Drug_Cst)2024 Drug cost: $13,478 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015116196$35,219
2016256511$45,878
20175161,297$182,615
20184291,063$422,041
2019380915$446,492
2020286706$459,443
2021206430$230,943
2022151312$11,337
2023305599$14,621
2024385757$13,478

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more337337$67
11102Biopsy of related skin growth, first growth259298$67
88331Pathology examination of specimen during surgery, first tissue block339629$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more290384$63
17000Destruction of precancer skin growth, 1 growth260293$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AcitretinAcitretin12360$2,751
Triamcinolone AcetonideTriamcinolone Acetonide1084,775$1,634
Clobetasol PropionateClobetasol Propionate321,011$1,614
KetoconazoleKetoconazole743,098$1,037
Mometasone FuroateMometasone Furoate481,607$784

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Ryan T. Rogers, MD?

Tedicare shows public-source Medicare data for Ryan T. Rogers, MD (NPI 1396065470), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan T. Rogers, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan T. Rogers, MD?

Ryan T. Rogers, MD is linked to PADRE DERMATOLOGY PLLC (billing NPI 1215302427) in the available physician profile data.

Does Ryan T. Rogers, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.